To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Social Welfare.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HF0A8F151B0AE42A29EEC720C3A7C1825: 1. Short title This Act may be cited as the Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2023 or the FORWARD Act of 2023....
- Section H91B209D420A144A8B3BF79274C937DC5: 2. Continuing support for research on endemic fungal diseases The Public Health Service Act is amended by inserting after section 447D of such Act (42 U.S.C....
- Section H173439290A6145ED9F73BF4BC2E1B205: 447E. Endemic fungal diseases The Director of the Institute shall— continue to conduct or support basic, translational, and clinical research related to fungal...
- Section HCCB6DA7909AB4C6CA1ABB44AE3FF51D0: 3. Endemic fungal disease working group The Secretary of Health and Human Services (referred to in this section as the Secretary) shall establish a working...
- Section H3AA704F927EA4EB0856DA81EE8C866E6: 4. Expanding tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis Section 524(a)(3) of the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Social Welfare
Primary Purpose
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMr. Schweikert (for himself, Mr. McCarthy, Mr. Valadao, Mr. LaMalfa, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology